{"transactions":[{"id":781459,"issuer":{"id":6521,"kind":"organization","name":"LifeMD, Inc."},"owners":[{"id":47785,"kind":"person","name":"Kavthekar Atul","position":1,"cik":"0001703619","reported_name":"Kavthekar Atul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-13T21:12:09.000Z","date":"2026-05-11","kind":"grant","planned":false,"acquired":true,"shares":337500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of restricted stock units which vest 112,500 on March 16, 2027, 112,500 on March 16, 2028 and the remainder on March 16, 2029."}],"balance_after":337500,"source":{"system":"sec-edgar","filing":"0000912282-26-000709","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/948320/000091228226000709/form4.xml","form_type":"4"}},{"id":1790898,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":47785,"kind":"person","name":"Kavthekar Atul","position":1,"cik":"0001703619","reported_name":"Kavthekar Atul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-09-01T20:07:38.000Z","date":"2023-08-02","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted stock units (\"RSUs\"). Each RSU represents a right to receive one share of Class A common stock of P3 Health Partners Inc. (the \"Issuer\"). The RSUs vest in four equal annual installments beginning August 2, 2024, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":768868,"source":{"system":"sec-edgar","filing":"0001104659-23-097747","document":"tm2325336-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703619/000110465923097747/tm2325336-1_4seq1.xml","form_type":"4"}},{"id":1891592,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":47785,"kind":"person","name":"Kavthekar Atul","position":1,"cik":"0001703619","reported_name":"Kavthekar Atul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-05-16T22:15:32.000Z","date":"2023-05-15","kind":"purchase","planned":false,"acquired":true,"shares":18868,"price":2.6499,"value":49998.3132,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The price reported is a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $2.6388 to $2.65, inclusive. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."}],"balance_after":18868,"source":{"system":"sec-edgar","filing":"0001104659-23-061504","document":"tm2316004-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703619/000110465923061504/tm2316004-1_4seq1.xml","form_type":"4"}},{"id":2086535,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":47785,"kind":"person","name":"Kavthekar Atul","position":1,"cik":"0001703619","reported_name":"Kavthekar Atul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-14T21:16:41.000Z","date":"2022-12-12","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable with respect to 25% of the shares on December 12, 2023 (the \"Initial Vesting Date\"), and the remaining 75% will vest in equal annual installments over the following three years on each anniversary of the Initial Vesting Date, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":600000,"derivative":{"exercise_price":3.7,"expiration_date":"2032-12-12","underlying":"Class A Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001104659-22-126979","document":"tm2232652-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703619/000110465922126979/tm2232652-2_4seq1.xml","form_type":"4"}},{"id":3572080,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":47785,"kind":"person","name":"Kavthekar Atul","position":1,"cik":"0001703619","reported_name":"Kavthekar Atul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-01T20:57:25.000Z","date":"2019-03-29","kind":"sale","acquired":false,"shares":901,"price":5.815,"value":5239.315,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 represent shares sold to cover the tax liability incurred incident to the delivery of shares of common stock from previously awarded Restricted Stock Units."}],"balance_after":26052,"source":{"system":"sec-edgar","filing":"0001596771-19-000032","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703619/000159677119000032/primary_doc.xml","form_type":"4"}},{"id":3584684,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":47785,"kind":"person","name":"Kavthekar Atul","position":1,"cik":"0001703619","reported_name":"Kavthekar Atul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-20T20:17:47.000Z","date":"2019-03-19","kind":"sale","acquired":false,"shares":1265,"price":5.8436,"value":7392.154,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 represent shares sold to cover the tax liability incurred incident to the delivery of shares of common stock from the previously awarded restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $5.80 to $5.8525 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":26953,"source":{"system":"sec-edgar","filing":"0001596771-19-000026","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1703619/000159677119000026/primary_doc.xml","form_type":"4"}},{"id":3584683,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":47785,"kind":"person","name":"Kavthekar Atul","position":1,"cik":"0001703619","reported_name":"Kavthekar Atul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-20T20:17:47.000Z","date":"2019-03-18","kind":"grant","acquired":true,"shares":15118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 27, 2018, Mr. Kavthekar was granted restricted stock units that were subject to the issuer's satisfaction of certain financial performance criteria. On March 18, 2019 (the \"determination date\"), the performance criteria was met with respect to 15,118 restricted stock units. One-third of the restricted stock units vested upon the determination date, and the remaining two-thirds will vest in two equal installments on each anniversary of the determination date, subject to continued employment."}],"balance_after":28218,"source":{"system":"sec-edgar","filing":"0001596771-19-000026","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703619/000159677119000026/primary_doc.xml","form_type":"4"}},{"id":3979749,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":47785,"kind":"person","name":"Kavthekar Atul","position":1,"cik":"0001703619","reported_name":"Kavthekar Atul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option to Acquire Common Stock","published_at":"2018-03-29T20:19:21.000Z","date":"2018-03-27","kind":"grant","acquired":true,"shares":26384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted in connection with the Issuer's equity incentive plan. One-third of the options will vest on each of the first, second and third anniversary of the grant date."}],"balance_after":26384,"derivative":{"exercise_price":20.52,"expiration_date":"2028-03-27","underlying":"Common Stock","underlying_shares":26384},"source":{"system":"sec-edgar","filing":"0001596771-18-000037","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1703619/000159677118000037/primary_doc.xml","form_type":"4"}},{"id":3979748,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":47785,"kind":"person","name":"Kavthekar Atul","position":1,"cik":"0001703619","reported_name":"Kavthekar Atul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-29T20:19:21.000Z","date":"2018-03-27","kind":"grant","acquired":true,"shares":11100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (\"RSUs\") were granted in connection with the Issuer's equity incentive plan.  One-third of the RSUs will vest on each of the first, second and third anniversary of the grant date."}],"balance_after":13100,"source":{"system":"sec-edgar","filing":"0001596771-18-000037","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703619/000159677118000037/primary_doc.xml","form_type":"4"}},{"id":4156602,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":47785,"kind":"person","name":"Kavthekar Atul","position":1,"cik":"0001703619","reported_name":"Kavthekar Atul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-11-20T15:57:41.000Z","date":"2017-11-20","kind":"purchase","acquired":true,"shares":2000,"price":15,"value":30000.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001703619-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703619/000170361917000001/primary_doc.xml","form_type":"4"}},{"id":4338228,"issuer":{"id":151818,"kind":"organization","name":"Diplomat Pharmacy, Inc.","symbol":"DPLO"},"owners":[{"id":47785,"kind":"person","name":"Kavthekar Atul","position":1,"cik":"0001703619","reported_name":"Kavthekar Atul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option to Acquire Common Stock","published_at":"2017-05-02T20:42:54.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in annual increments of 25% of the option grant beginning on the one-year anniversary of the grant date."}],"balance_after":200000,"derivative":{"exercise_price":16,"expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001596771-17-000037","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703619/000159677117000037/primary_doc.xml","form_type":"4"}}]}